04423cam a22006257i 450000100090000000300060000900500170001500800410003201000170007303500240009004000630011404200140017705000240019108200210021508600170023624501250025325000170037826401740039526400120056930000660058133600260064733700280067333800270070149000460072849000480077450000330082250400410085550513620089653602560225858801030251465000690261765000720268665000740275865000740283265000440290665000440295065000430299465000360303765000330307365000320310665000400313865000380317865000350321665100190325165100250327065500140329565500330330965500340334271000640337671000410344083000550348183000500353685600820358685601290366821065234PUCPR20250304151959.0190709s2018    mdua     b   f000 0 eng    a  2019410152  a(OCoLC)on1056250398  aZ84cZ84erdadOCLCOdOCLCAdOCLCFdOCLCOdOCLCAdDLCbspa  alccopycat00aRC568.O45bM49 201800a362.29/30973223  aHE 20.418:6300aMedications for opioid use disorder :bfor healthcare and addiction professionals, policymakers, patients, and families.  aUpdated 2020 1a[Rockville, Md.] :bU.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment,c2018. 4c♭2018  aiii, approximately 322 pages :bcolor illustrations ;c28 cm.  atext2rdacontentbtxt  aunmediated2rdamediabn  avolume2rdacarrierbnc1 aTreatment improvement protocol, TIP ;v631 aHHS publication ;vno. (SMA) 18-5063FULLDOC  a"Printed 2018"-- back cover.  aIncludes bibliographical references.0 aPart 1: An introduction to medications for the treatment of opioid use disorder. The approach to OUD care -- Overview of medications for OUD -- Duration of treatment with OUD medication -- Treatment settings -- Challenges to expanding access to OUD medication -- Resources -- Notes -- Part 2: Addressing opioid use disorder in general medical settings. Scope of the Problem -- Screening -- Assessment -- Treatment planning or referral -- Resources -- Appendix -- Notes -- Part 3: Pharmacotherapy for opioid use disorder. Pharmacotherapy for opioid use disorder -- Overview of pharmacotherapy for opioid use disorder. Methadone -- Naltrexone -- Buprenorphine -- Medical management strategies for patients taking OUD medications in office-based settings -- Medical management of patients taking OUD medications in hospital settings -- PART 4: Partnering addiction treatment counselors with clients and healthcare professionals. Overview and context -- Quick guide to medications -- Counselor-prescriber communications -- Creation of a supportive counseling experience -- Other common counseling concerns -- Notes -- Part 5: Resources related to medications for opioid use disorder. General Resources -- Resources for counselors and peer providers -- Resources for clients and families -- Provider tools and sample forms -- Glossary of TIP terminology -- Notes  aPrepared by the Knowledge Application Program (KAP) for the Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services (HHS) under contract numberb270-14-0445  aDescription based on online resource; title from PDF cover (SAMHSA website, viewed Aug. 13, 2018). 0aOpioid abusexTreatmentzUnited StatesvHandbooks, manuals, etc. 0aOpioid abusexChemotherapyzUnited StatesvHandbooks, manuals, etc. 0aOpioidsxOverdosexTreatmentzUnited StatesvHandbooks, manuals, etc. 0aDrug addictsxRehabilitationzUnited StatesvHandbooks, manuals, etc.12aOpioid-Related Disordersxdrug therapy.22aOpiate Substitution Treatmentxmethods.22aNarcotic Antagonistsxtherapeutic use.22aBuprenorphinextherapeutic use.22aNaltrexonextherapeutic use.22aMethadonextherapeutic use. 7aDrug addictsxRehabilitation.2fast 7aOpioid abusexChemotherapy.2fast 7aOpioid abusexTreatment.2fast 2aUnited States. 7aUnited States.2fast 2aHandbook. 7aHandbooks and manuals.2fast 7aHandbooks and manuals.2lcgft2 aCenter for Substance Abuse Treatment (U.S.),eissuing body.2 aKnowledge Application Program (U.S.) 0aTreatment improvement protocol (TIP) series ;v63. 0aDHHS publication ;vno. (SMA) 18-5063FULLDOC.403Available in PDF, Mobi and epub versionsuhttps://purl.fdlp.gov/GPO/gpo1073384 zAddress at time of PURL creation3PDF versionuhttps://store.samhsa.gov/shin/content/SMA18-5063FULLDOC/SMA18-5063FULLDOC.pdf